After treatment with the antibody, tumor cells showed a decrease in KIT expression, leading the authors to consider that the mechanism by which the antibodies affect the cells is a downregulation of KIT, and through augmenting phagocytosis of GIST cells by macrophages [34]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.